TNF and inflammatory bowel disease: Such protein therapeutics should include the anti-inflammatory cytokine IL-10, antibodies against the pro-inflammatory cytokine TNF-α, and the extracellular domain of the TNF-α receptor, each of which has shown potential effectiveness for the therapy of IBD.